US 10358501
HER3 specific monoclonal antibodies for diagnostic and therapeutic use
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 10358501 (HER3 specific monoclonal antibodies for diagnostic and therapeutic use) held by The Board of Regents of the University of Texas System expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06, A61P